3 results match your criteria: "Hospital de La Moncloa[Affiliation]"
A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients.
Med Intensiva (Engl Ed)
January 2023
ICU, Hospital Universitario Joan XXIII/URV/IISPV, Tarragona, Spain; CIBERES/CIBERESUCICOVID. Electronic address:
Objective: To determine if the use of corticosteroids was associated with Intensive Care Unit (ICU) mortality among whole population and pre-specified clinical phenotypes.
Design: A secondary analysis derived from multicenter, observational study.
Setting: Critical Care Units.
A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients.
Med Intensiva
January 2023
ICU, Hospital Universitario Joan XXIII/URV/IISPV, Tarragona, Spain.
Objective: To determine if the use of corticosteroids was associated with Intensive Care Unit (ICU) mortality among whole population and pre-specified clinical phenotypes.
Design: A secondary analysis derived from multicenter, observational study.
Setting: Critical Care Units.
[Prophylaxis and treatment of respiratory distress syndrome with different surfactants].
An Esp Pediatr
January 2002
Servicio de Pediatría, Hospital de La Moncloa, Madrid, Spain.
Article Synopsis
- The study investigates the effectiveness of different exogenous surfactants for treating respiratory distress syndrome in premature infants.
- Natural surfactants, particularly porcine-derived ones, are shown to improve oxygenation more rapidly and have lower complication rates compared to synthetic options.
- The findings suggest poractant-alfa (porcine) is preferable over beractant (bovine) due to better outcomes, though more research is needed to confirm these advantages.